Ellen Nollen

Ellen Nollen currently holds a Rosalind Franklin Fellowship at the Department of Ageing of ERIBA, where she is studying the molecular basis of Parkinson’s disease and other aging-associated neurodegenerative diseases. In July 2011 she was awarded an ERC Starting Independent Researcher Grant (€1.5 million) to work on ‘Protein damage control: regulation of toxic protein aggregation in aging-associated neurodegenerative diseases’, In November 2011 she was named as an EMBO Young Investigator. In 2007 she received an Alfred Tissières Young Investigator Award.

Ellen Nollen previously worked as a postdoctoral fellow in the Dept. of Functional Genomics, Hubrecht Laboratory, Utrecht, under Prof. Ronald Plasterk, for which she had an NWO-VENI grant, and in the Dept. of Biochemistry, Northwestern University, Evanston, USA, under Prof. Rick Morimoto, during which she was supported by NWO-Talent and EMBO long-term fellowships. She completed her PhD thesis on “Hsp70 chaperone functions in stressed cells” in 2000 under Prof. Harm Kampinga at the University of Groningen.

• Sin O, de Jong T, Kudron M , Zaini A , Aprile FA , Seinstra R, Mata-Cabana A, Stroo E, Willinge Prins R, Martineau C, Wang HH, Hogewerf W, Steinhof A, Wanker EE, Vendruscolo M, Calkhoven CF, Reinke V, Guryev V, Nollen EAA. (2017) Identification of an RNA Pol III-associated regulator of small non-coding RNAs that is linked with disease-associated protein agregation. Molecular Cell.
  • View abstract
  • View PDF
• Perni M , Galvagnion C, Maltsev A, Meisl G, Müller MB, Challa PK, Kirkegaard JB, Flagmeier P, Cohen SI, Cascella R, Chen SW, Limboker R, Sormanni P, Heller GT, Aprile FA, Cremades N, Cecchi C, Chiti F, Nollen EA, Knowles TP, Vendruscolo M, Bax A, Zasloff M, Dobson CM.(2017) A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity. PNAS.
  • View abstract
  • View PDF
• Koopman M , Michels H , Dancy BM, Kamble R, Mouchiroud L, Auwerx J, Nollen EA, Houtkooper RH. (2016) A screening-based platform for the assessment of cellular respiration in Caenorhabditis elegans. Nature Protocols.
  • View abstract
  • View PDF
• van der Goot AT, Nollen EA. (2013) Tryptophan metabolism: entering the field of aging and age-related pathologies. Trends in Molecular Medicine.
  • View abstract
  • View PDF
• van der Goot AT, Zhu W, Vázquez-Manrique RP, Seinstra RI, Dettmer K, Michels H, Farina F, Krijnen J, Melki R, Buijsman RC, Ruiz Silva M, Thijssen KL, Kema IP, Neri C, Oefner PJ, Nollen EA. (2012) Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation. PNAS.
  • View abstract
  • View PDF
• Falsone SF, Meyer NH, Schrank E, Leitinger G, Pham CL, Fodero-Tavoletti MT, Holmberg M, Dulle M, Scicluna B, Gesslbauer B, Rückert HM, Wagner GE, Merle DA, Nollen EA, Kungl AJ, Hill AF, Cappai R, Zangger K. (2012) SERF protein is a direct modifier of amyloid fiber assembly. Cell Reports.
  • View abstract
  • View PDF
• Teuling E, Bourgonje A, Veenje S, Thijssen K, de Boer J, van der Velde J, Swertz M, Nollen E. (2011) Modifiers of mutant huntingtin aggregation: functional conservation of C. elegans-modifiers of polyglutamine aggregation. PLoS Currents.
  • View abstract
  • View PDF
• van Ham TJ, Holmberg MA, van der Goot AT, Teuling E, Garcia-Arencibia M, Kim HE, Du D, Thijssen KL, Wiersma M, Burggraaff R, van Bergeijk P, van Rheenen J, Jerre van Veluw G, Hofstra RM, Rubinsztein DC, Nollen EA. (2010) Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity. Cell.
  • View abstract
  • View PDF
• van Ham TJ, Breitling R, Swertz MA, Nollen EA. (2009) Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms. EMBO Molecular Medicine.
  • View abstract
  • View PDF
• van Ham TJ, Thijssen KL, Breitling R, Hofstra RM, Plasterk RH, Nollen EA. (2008) C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genetics.
  • View abstract
  • View PDF